Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPACK vs Sciatic Block in TKR
NCT06514365Recruiting
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Jun 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in pain (2 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoints: Pain at rest at 48 hours, Pain with movement at 48 hours and 1 more. Started Jun 2020; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06514365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514365.